Yael L. Maxwell
@TCTMD_Yael
Followers
4K
Following
5K
Media
814
Statuses
6K
Senior Medical Journalist @TCTMD & #FellowsForum Section Editor. Mama to 2 tiny humans. Student of the world. All tweets my own. @yaelmaxwell.bsky.social
Joined October 2011
I set up a Signal account if anyone would prefer to reach me there.
0
1
2
In this episode of Fellows Forum, @TCTMD_Yael talks with @GrantReedMD, @AngeloOliva3, and @RaunakNairMD on how they broach difficult conversations with patients and educate other practitioners to do them effectively and empathically. #TCT2025
https://t.co/ryBmqQk6bT
0
3
8
During #TCT2025, @TCTMD_Yael, Brittany Zwischenberger, and Milan Milojevic talk about the continuing optimization of CABG and the latest advancements to come. Watch the latest On Record now: https://t.co/HMSJkE1D2M
0
1
1
Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV https://t.co/Xtdfuyp1pv
0
5
13
Watch Suzanne J. Baron discuss the Short-CUT trial at #TCT2025, which compared cutting balloon angioplasty with IVL for patients with calcified CAD. Read the in-depth story on TCTMD: https://t.co/FbHXxgVe3P
1
2
9
Performing PCI to open up the graft for patients with failed SVGs after CABG reduces the rate of major CV events compared with intervening on the bypassed native coronary artery, according to results from the PROCTOR trial. #TCT2025
https://t.co/SG7luNfvyX
0
5
8
There's new exciting fish oil data, this time in patients on dialysis. What say you: believable or too good to be true? @charmaine_lok
https://t.co/BN3StR7GfG
tctmd.com
With such a large reduction, coupled with general skepticism around PUFAs, experts would like to see the trial replicated.
0
0
0
The latest episode of Beyond the Data has @mmamas1973 discussing the results of the PROCTOR trial with Ruben de Winter and Paul Knaapen during #TCT2025. https://t.co/clfBTbemmL
0
7
19
What a pleasure it was so cover another TCT with this crew (I’ve lost track of my total count by this point). @TCTMD_Caitlin @michaelTCTMD @ToddNeale & @lamckeown1 (we missed you!), you’re all rockstars. Check out all our #TCT2025 team coverage on @TCTMD. https://t.co/FQyrIl2yFv
0
7
18
Playing music in the cath lab before and during PCI has a beneficial effect on cardiovascular health, significantly cutting postprocedural mean systolic blood pressure, according to results of a small pilot study. #TCT2025
https://t.co/SjUTK6CE3r
4
13
64
TMVR with Tendyne successfully treats mitral regurgitation or stenosis complicated by severe MAC while also improving HF symptoms and QoL, according to the SUMMIT-MAC study #TCT2025 @psorajja @PhilGenereuxMD @Drroxmehran @MayraGuerreroMD @TsuyoshiKaneko1
https://t.co/E4BO0WF1Vx
tctmd.com
The device, which is delivered transapically, represents an option for very sick patients who previously have had none.
0
6
20
Oh hey #FellowsForum at #TCT2025! Make sure to reach out if you’re a current trainee interested in writing for us or being featured. On my way to the @TCTMD Studio now to film with some fellows!
0
2
3
Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions https://t.co/NGdSc35TGq
0
5
16
Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION
tctmd.com
The DCB is meant to address long-term stent-related complications and avoid adding yet another metal layer in ISR.
0
3
2
Proponents of transcatheter tricuspid valve interventions for severe TR are reassured by new data presented at #TCT2025, but only longer-term follow-up will truly answer safety and efficacy Qs, they say. @drrahulpsharma @jgschwartzmd @djc795 @azeemlatib
https://t.co/4Uj4zX4T0a
tctmd.com
The real-world Evoque and new TRILUMINATE findings provide an “extension” from the pivotal trials, Dharam Kumbhani says.
0
1
7
Hello from #TCT2025 ! @TCTMD turns 25 this year and I couldn’t be prouder of @TCTMD_Yael @lamckeown1 @ToddNeale @michaelTCTMD
1
3
10